Michael Garone
CIK 1307553 · Chief Financial Officer · last filed 2017-07-06
Michael Garone is a Chief Financial Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for IMMU, was dated Jul 6, 2017.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
13
$0
Filer Profile
75 PASSAIC AVENUE
FAIRFIELD, NJ 07004
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Financial Officer | — | — | — | $0 | 2 | 2017-07-06 |
| EMIS | Chief Financial Officer | — | $10.27 | — | $0 | 1 | 2007-08-31 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-07-06 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-07-05 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-04-11 | — | Grant (A) | — | $0 | |
| 2015-03-05 | — | Grant (A) | — | $0 | |
| 2015-01-15 | — | Grant (A) | — | $0 | |
| 2014-01-22 | — | Grant (A) | — | $0 | |
| 2013-01-16 | — | Grant (A) | — | $0 | |
| 2012-06-04 | — | Grant (A) | — | $0 | |
| 2011-07-19 | — | Grant (A) | — | $0 | |
| 2010-09-17 | — | Buy (P) | +100,000 | $108.6K |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.